PDS Biotechnology Corporation. (NASDAQ:PDSB) Q1 2022 Earnings Conference Call May 11, 2022 8:00 AM ET
Company Participants
Gabrielle DeGravina - Investor Relations, CG Capital
Frank Bedu-Addo - Chief Executive Officer
Lauren Wood - Chief Medical Officer
Matthew Hill - Chief Financial Officer
Conference Call Participants
Louise Chen - Cantor Fitzgerald
Leland Gershell - Oppenheimer
Laura Suriel - Alliance Global Partners
Robert LeBoyer - Noble Capital
Operator
Hello and welcome to PDS Biotechnology First Quarter 2022 Earnings Call and Webcast. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions]. As a reminder, this conference is being recorded.
It's now my pleasure to turn the call over to Gabby DeGravina. Please go ahead.
Gabrielle DeGravina
Good morning. And welcome to PDS Biotechnology's first quarter 2022 earnings conference call and audio webcast. With me today from the company are Dr. Frank Bedu-Addo, Chief Executive Officer, Dr. Lauren B. Wood, Chief Medical Officer, and Matt Hill, Chief Financial Officer.
Earlier this morning, PDS Biotech issued a press release announcing financial results for the quarter ended March 31, 2022. We encourage everyone to read the press release as well as PDS Biotech's report on Form 10-Q, which was filed with the SEC earlier this morning. The company's press release is available on the PDS website at pdsbiotech.com and the 10-Q should be posted later today.
In addition, this conference call is being webcast and will be archived on the company website for future reference.
Before we begin, we need to remind everyone that, on today's call, the company will be making forward-looking statements regarding regulatory and product candidate development plans, as well as research activities. These statements are subject to risks and uncertainties that may cause actual results to differ from those forecasted. A description of these risks can be found in the PDS Biotech's most recent filings with the SEC. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this conference call. Except to the extent required by applicable law or regulation, PDSB undertakes no obligation to update the forward-looking statements included today to reflect subsequent events or circumstances.
As you can see, we are using a different format for the earnings call today. Relying on slides to help summarize programs and milestones and aiming to streamline the presentation of background information and updates. We know your time is a precious commodity and we [Indiscernible] there’s much time as possible for Q&A. Your feedback on this new structure would be welcome.